R Citro
University of Insubria
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by R Citro.
Heart Failure Clinics | 2013
R Citro; Federico Piscione; Guido Parodi; Jorge A. Salerno-Uriarte; Eduardo Bossone
Takotsubo cardiomyopathy (TTC) is characterized by transient and reversible left ventricular (LV) systolic dysfunction due to extended myocardial stunning. Despite a good long term prognosis, approximately one-third of patients with TTC experience life-threatening complications during the acute phase. Echocardiography is the first imaging modality for an early evaluation of LV systolic and diastolic function in patients with TTC. Moreover, echocardiography allows the detection of specific findings associated with TTC, such as LV outflow tract obstruction, mitral regurgitation, and right ventricular involvement, providing crucial information for clinical management and therapy and for monitoring myocardial function recovery during the follow-up.
Cell Death and Disease | 2015
Morena d'Avenia; R Citro; M De Marco; Angelo Veronese; Alessandra Rosati; Rosa Visone; Stefanos Leptidis; Leonne E. Philippen; G Vitale; A Cavallo; Angelo Silverio; C Prota; P Gravina; A De Cola; Erminia Carletti; G Coppola; S Gallo; G Provenza; Eduardo Bossone; Federico Piscione; Michael Hahne; L. De Windt; Maria Caterina Turco; V De Laurenzi
Molecular mechanisms protecting cardiomyocytes from stress-induced death, including tension stress, are essential for cardiac physiology and defects in these protective mechanisms can result in pathological alterations. Bcl2-associated athanogene 3 (BAG3) is expressed in cardiomyocytes and is a component of the chaperone-assisted autophagy pathway, essential for homeostasis of mechanically altered cells. BAG3 ablation in mice results in a lethal cardiomyopathy soon after birth and mutations of this gene have been associated with different cardiomyopathies including stress-induced Takotsubo cardiomyopathy (TTC). The pathogenic mechanism leading to TTC has not been defined, but it has been suggested that the heart can be damaged by excessive epinephrine (epi) spillover in the absence of a protective mechanism. The aim of this study was to provide more evidence for a role of BAG3 in the pathogenesis of TTC. Therefore, we sequenced BAG3 gene in 70 TTC patients and in 81 healthy donors with the absence of evaluable cardiovascular disease. Mutations and polymorphisms detected in the BAG3 gene included a frequent nucleotide change g2252c in the BAG3 3′-untranslated region (3′-UTR) of Takotsubo patients (P<0.05), resulting in loss of binding of microRNA-371a-5p (miR-371a-5p) as evidenced by dual-luciferase reporter assays and argonaute RNA-induced silencing complex catalytic component 2/pull-down assays. Moreover, we describe a novel signaling pathway in cardiomyocytes that leads to BAG3 upregulation on exposure to epi through an ERK-dependent upregulation of miR-371a-5p. In conclusion, the presence of a g2252c polymorphism in the BAG3 3′-UTR determines loss of miR-371a-5p binding and results in an altered response to epi, potentially representing a new molecular mechanism that contributes to TTC pathogenesis.
Journal of Cardiovascular Medicine | 2017
R Citro; Cesare Baldi; Patrizio Lancellotti; Angelo Silverio; G Provenza; Michele Bellino; Di Muro; Generoso Mastrogiovanni; R De Rosa; Gennaro Galasso; E Bosonne; P Giudice; Federico Piscione
Aim The aim of this study was to assess preoperative determinants, prevalence, and prognostic impact of left ventricular (LV) reverse remodeling (LVRR) in patients with secondary mitral regurgitation (SMR), undergoing MitraClip implantation (MCi). Methods From March 2012 to January 2015, a total of 41 consecutive patients with moderate-to-severe SMR treated successfully with MCi were enrolled. All patients underwent clinical and echocardiographic follow-up after MCi. Global longitudinal strain (GLS) was obtained using two dimensional speckle tracking analysis. A reduction in LV end-systolic volume more than 10% compared with baseline was considered as a marker of LVRR. Patients were divided into two groups according to the presence or absence of LVRR. Cardiac events were defined as the occurrence of cardiac death, rehospitalization for worsening heart failure, and mitral valve surgery. Results On univariable analysis, EuroSCORE II and GLS were associated with LVRR. On multivariable logistic regression analysis, GLS was the only independent correlate of LVRR (P = 0.004). A receiver operating characteristic curve identified a cutoff value for GLS of −9.25% (P < 0.001) associated with LVRR, with a sensitivity and specificity of 81 and 74%, respectively. New York Heart Failure Association class more than 2 after MCi, absence of LVRR after MCi, and preoperative GLS more than −9.25% were significantly correlated with adverse cardiac events at long-term follow-up. On multivariable logistic regression analysis, GLS was the only independent predictor of composite adverse cardiac events at 2-year follow-up. Conclusion A worse preoperative GLS predicts no LVRR and is associated with adverse long-term outcome after successful MCi for SMR.
Jacc-cardiovascular Imaging | 2014
R Citro; Fausto Rigo; Antonello D'Andrea; Quirino Ciampi; Guido Parodi; Gennaro Provenza; Raffaele Piccolo; Marco Mirra; Concetta Zito; Roberta Giudice; Marco Mariano Patella; Francesco Antonini-Canterin; Eduardo Bossone; Federico Piscione; Jorge A. Salerno-Uriarte
Cell Death and Disease | 2013
M De Marco; Antonia Falco; Anna Basile; Alessandra Rosati; Michelina Festa; Morena d'Avenia; Maria Pascale; F Dal Piaz; Rita Bisogni; Daniela Barcaroli; G Coppola; Federico Piscione; Alberto Gigantino; R Citro; R De Rosa; Gennaro Vitulano; N Virtuoso; F Manganelli; E Palermo; F Siano; G Rosato; Michael Hahne; C Tiberti; V De Laurenzi; Maria Caterina Turco
International Journal of Cardiology | 2016
R Citro; Eduardo Bossone; Guido Parodi; Scipione Carerj; Quirino Ciampi; Gennaro Provenza; Concetta Zito; Costantina Prota; Angelo Silverio; Olga Vriz; Antonello D'Andrea; Gennaro Galasso; Cesare Baldi; Fausto Rigo; Massimo F. Piepoli; Jorge A. Salerno-Uriarte; Federico Piscione
Jacc-Heart Failure | 2014
Margot De Marco; Raffaella D’Auria; Alessandra Rosati; Gennaro Vitulano; Alberto Gigantino; R Citro; Federico Piscione; Jodi Zilinski; James L. Januzzi; Maria Caterina Turco
European Heart Journal | 2018
Angelo Silverio; Cesare Baldi; M Di Maio; D Bonadies; G Verolino; L Esposito; F M Cogliani; G Fierro; M R Di Muro; R De Rosa; Pietro Giudice; R Citro; Federico Piscione; G. Galasso
European Heart Journal | 2018
Angelo Silverio; R De Rosa; Cesare Baldi; M Di Maio; Costantina Prota; Ilaria Radano; Eva Herrmann; Julia Rey; R Citro; Federico Piscione; G. Galasso
Archive | 2008
Eduardo Bossone; San Raffaele; Dipartimento Cardiorespiratorio; Padiglione Sacco; Ospedale Maggiore Milano; Via F. Sforza; E. Bossone; Santi Trimarchi; Gloria Esposito; Stefano Aliberti; R Citro; Luigi Allegra; Francesco Blasi